Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-25 @ 7:01 PM
Study NCT ID:
NCT05075304
Status:
TERMINATED
Last Update Posted:
2024-05-21
First Post:
2021-08-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients
Sponsor:
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-21
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-14
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-22
First Submit QC Date:
None
Study First Post Date:
2021-10-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-20
Last Update Post Date:
2024-05-21
Last Update Post Date Type:
ACTUAL